These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4208441)

  • 41. Prolactin release after injection of thyrotrophin-releasing hormone in man.
    L'Hermite M; Copinschi G; Golstein J; Vanhaelst L; Leclercq R; Bruno OD
    Lancet; 1972 Apr; 1(7754):763-5. PubMed ID: 4111244
    [No Abstract]   [Full Text] [Related]  

  • 42. Anorexia nervosa: behavioural and hypothalamic aspects.
    Vigersky RA; Loriaux DL; Andersen AE; Lipsett MB
    Clin Endocrinol Metab; 1976 Jul; 5(2):517-35. PubMed ID: 821681
    [No Abstract]   [Full Text] [Related]  

  • 43. Interaction between thyrotrophin, corticotrophin and growth hormone secretion in man.
    Besser GM; Ratcliffe JG; Kilborn JR; Ormston BJ; Hall R
    J Endocrinol; 1971 Dec; 51(4):699-706. PubMed ID: 4333071
    [No Abstract]   [Full Text] [Related]  

  • 44. Thyrotrophin responses to intravenous thyrotrophin-releasing hormone in patients with hypothalamic and pituitary disease.
    McLaren EH; Hendricks S; Pimstone BL
    Clin Endocrinol (Oxf); 1974 Apr; 3(2):113-22. PubMed ID: 4366312
    [No Abstract]   [Full Text] [Related]  

  • 45. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors.
    Kletzky OA; Davajan V; Mishell DR; Nicoloff JT; Mims R; March CM; Nakamura RM
    J Clin Endocrinol Metab; 1977 Oct; 45(4):631-40. PubMed ID: 410820
    [No Abstract]   [Full Text] [Related]  

  • 46. Normal pituitary hormone response to thyrotrophin and gonadotrophin releasing hormones in subjects exposed to elemental mercury vapour.
    Erfurth EM; Schütz A; Nilsson A; Barregård L; Skerfving S
    Br J Ind Med; 1990 Sep; 47(9):639-44. PubMed ID: 2119795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circulating levels of anterior pituitary hormones and insulin after arginine infusion.
    Cremer GM; Bilstad JM; Faiman C; Moxness KE
    Mayo Clin Proc; 1968 Nov; 43(11):776-82. PubMed ID: 4885979
    [No Abstract]   [Full Text] [Related]  

  • 48. [Investigations concerning the effect of synthetic "thyrotropin releasing factor" (TRF) in patients with thyroid gland function disorders and in healthy controls].
    zur Mühlen A von ; Köbberling J; Hesch RD; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():76. PubMed ID: 4101597
    [No Abstract]   [Full Text] [Related]  

  • 49. The effect of danazol on anterior pituitary function.
    Franchimont P; Cramilion C
    Fertil Steril; 1977 Aug; 28(8):814-7. PubMed ID: 407104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide.
    Bowers CY; Friesen HG; Hwang P; Guyda HJ; Folkers K
    Biochem Biophys Res Commun; 1971 Nov; 45(4):1033-41. PubMed ID: 5000704
    [No Abstract]   [Full Text] [Related]  

  • 51. Growth hormone-releasing activity of growth hormone-releasing peptide-1 (a synthetic heptapeptide) in children and adolescents.
    Laron Z; Bowers CY; Hirsch D; Almonte AS; Pelz M; Keret R; Gil-Ad I
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):424-6. PubMed ID: 8279223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthetic thyrotropin-releasing hormone. Activity in men and women, specificity of action, inhibition by triiodothyronine, and activity orally.
    Bowers CY; Schally AV; Kastin A; Arimura A; Schalch DS; Gual C; Castineda E; Folkers K
    J Med Chem; 1971 Jun; 14(6):477-81. PubMed ID: 4997121
    [No Abstract]   [Full Text] [Related]  

  • 53. Alteration by prolonged oral administration of a thyrotropin-releasing hormone analog, TA-0910, of the pituitary-thyroid axis in subjects with brain stroke.
    Miyashita K; Murakami M; Satoh T; Monden T; Yamada M; Iriuchijima T; Kazihara A; Mori M
    Intern Med; 1993 Sep; 32(9):681-5. PubMed ID: 8142670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The specificity and application of a radioimmunoassay for the alpha-subunit of luteinizing hormone in man.
    Hagen C; McNeilly AS
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):664-74. PubMed ID: 168710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined pituitary function-test with four hypothalamic releasing hormones.
    Schopohl J; Losa M; König A; Müller OA; Stalla GK; von Werder K
    Klin Wochenschr; 1986 Apr; 64(7):314-8. PubMed ID: 3012190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between pituitary stalk (PS) visibility and the severity of hormone deficiencies: PS interruption syndrome revisited.
    Wang W; Wang S; Jiang Y; Yan F; Su T; Zhou W; Jiang L; Zhang Y; Ning G
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):369-76. PubMed ID: 25845766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accidental hypothermia: endocrine function during recovery.
    Woolf PD; Hollander CS; Mitsuma T; Lee LA; Schalch DS
    J Clin Endocrinol Metab; 1972 Mar; 34(3):460-6. PubMed ID: 4622132
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of TRH and triiodothyronine on prolactin release in sheep.
    Debeljuk L; Arimura A; Redding T; Schally AV
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):421-3. PubMed ID: 4631992
    [No Abstract]   [Full Text] [Related]  

  • 59. Suppression of clonidine-induced release of growth hormone by thyrotropin releasing hormone in humans.
    Zanoboni A; Zanoboni-Muciaccia W; Zanussi C; Baraldi R
    J Endocrinol Invest; 1979; 2(4):347-51. PubMed ID: 119798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling.
    Gautvik KM; Tashjian AH; Kourides IA; Weintraub BD; Graeber CT; Maloof F; Suzuki K; Zuckerman JE
    N Engl J Med; 1974 May; 290(21):1162-5. PubMed ID: 4207375
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.